Cellebrite DI Ltd. logo

Cellebrite DI Ltd.

CLBT | NASDAQ
Chart Builder DCF Calculator
$11.52
-$0.04 (-0.35%)
Sep 22, 2026, 10:48 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
124.46M 191.66M 189.52M 87.65M 145.97M 128.71M
Short-Term Investments
312.59M 255.56M 113.41M 95.98M 35.59M 108.93M
Long-Term Investments
97.96M 36.6M 28.86M 22.13M n/a n/a
Other Long-Term Assets
14.62M 7.68M 12.89M 1.73M 1.96M 565K
Receivables
104.97M 82.36M 77.27M 78.76M 67.51M 66.32M
Inventory
7.6M 8.94M 9.94M 10.18M 6.51M 4.75M
Other Current Assets
6.6M 18.18M 23.06M 14.77M 7.88M 11.24M
Total Current Assets
575.85M 567.59M 422.08M 295.93M 273.21M 324.27M
Property-Plant & Equipment
38.52M 27.6M 30.16M 32.91M 16.76M 16.11M
Goodwill & Intangibles
201.03M 40.02M 37.42M 38.08M 38.06M 16.07M
Total Long-Term Assets
363M 122.97M 123.87M 107.36M 66.57M 40.12M
Total Assets
938.85M 690.57M 532.89M 403.29M 339.78M 364.39M
Account Payables
16.83M 11.08M 8.28M 4.61M 9.55M 4.73M
Deferred Revenue
278.24M 217.64M 196.59M 153.34M 123.68M 106.1M
Short-Term Debt
n/a n/a n/a n/a n/a n/a
Other Current Liabilities
n/a n/a 9.04M n/a n/a n/a
Total Current Liabilities
369.66M 295.5M 253.82M 207.78M 186.57M 159.38M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
16.68M 6.95M 188.59M 69.13M 190.13M 107.76M
Total Long-Term Liabilities
84.88M 59.05M 244.85M 121.65M 226.56M 141.2M
Total Liabilities
454.53M 354.55M 498.67M 329.43M 413.13M 300.58M
Total Debt
22.67M 10.97M 14.13M 15.36M n/a n/a
Book Value
484.32M 336.02M 34.21M 73.87M -73.35M 63.8M
Book Value Per Share
1.94 1.60 0.18 0.38 -0.45 0.34
Common Stock
n/a n/a n/a n/a n/a n/a
Retained Earnings
-86.54M -164.86M 118.14M 199.24M 78.44M 28.34M
Comprehensive Income
2.22M 2.09M 1.05M 331K 1.37M 1.32M
Shareholders Equity
484.32M 336.02M 34.21M 73.87M -73.35M 63.8M
Total Investments
410.55M 292.17M 142.27M 118.1M 35.59M 108.93M

© 2026 bestshares.com. All rights reserved.